Search results
Results From The WOW.Com Content Network
The Descartes Systems Group Inc. (commonly referred to as Descartes) is a Canadian multinational technology company specializing in logistics software, supply chain management software, and cloud -based services for logistics businesses. Descartes is perhaps best known for its abrupt and unexpected turnaround in the mid-2000s after coming close ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
x. AOL works best with the latest versions of the browsers. You're using an outdated or unsupported browser and some AOL features may not work properly.
Website. www.datamyne.com. Datamyne was a privately held corporation that provides access to a searchable database of import-export trade of 50 countries across five continents. The company was acquired by Descartes Systems Group in December 2016. The purchase price for the acquisition was approximately US$52.7 million in cash.
Visual Compliance is based in Canada and serves over 2,000 customers with over 67,500 subscribers operating in over 100 countries. Visual Compliance users include small business, research institutions, government organizations, Fortune 500 companies, and universities, scientific research institutions, among them NASA, MIT, University of Texas, University of Florida, among many others.
Call paid premium support at 1-800-358-4860 to get live expert help from AOL Customer Care. Having trouble signing in? Find out how to identify and correct common sign-in issues like problems with your username and password, account locks, looping logins, and other account access errors.
Login. In computer security, logging in (or logging on, signing in, or signing on) is the process by which an individual gains access to a computer system or program by identifying and authenticating themselves. User Credentials. Typically, user credentials consist of a username and a password. [1] These credentials themselves are sometimes ...
Relative to Descartes-08, Descartes-15 has been observed to achieve an approximately ten-fold increase in CAR expression and selective target-specific killing in preclinical studies. The Phase 1 dose escalation trial (NCT06304636) will assess the safety and tolerability of outpatient Descartes-15 administration in patients with multiple myeloma.